The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study

Barbara Rossetti, M Ferrara, L Taramasso, F Bai, F Lombardi, Nicoletta Ciccarelli, M Durante, F Alladio, I Rancan, F Montagnani, A Di Biagio, A d’Arminio Monforte, M Zazzi, M Fabbiani

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)161-161
Number of pages1
JournalEJIAS
Volume25
Publication statusPublished - 2022

Keywords

  • neuropsychiatric symptoms

Cite this